Upgrade to SI Premium - Free Trial

Aclaris Therapeutics (ACRS) Granted 2 Patents Allowance Applications for Baricitnib and Decernotinib

April 4, 2017 8:04 AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) today announced that Columbia University has received a Notice of Allowance from the United States ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles